Low-volume, point-of-need diagnostic assays via cell-free synthetic biology

Technology
In development
University

A novel cell-free synthetic biology-based technology for low-volume, visually interpretable micronutrient tests. Suitable for field applications, it offers colorimetric and fluorescent readouts for semi-quantitative and quantitative assessments, respectively.

Overview

This innovative solution uses cell-free synthetic biology to develop low-volume, visually interpretable assays for diagnostic applications. Using processed bacterial lysates, we leverage cellular functions like transcription and translation for in vitro sensing of molecular targets and transduction of that signal into measurable (and usually visually interpretable) outputs. This yields a user-friendly, point-of-need test that can provide colorimetric readouts for quick, semi-quantitative assessments or fluorescent readouts for more accurate, fully-quantitative measurements using simple devices like a cell phone.

Technical specifications
  • Cell-free system: Uses processed bacterial lysate to perform transcription and translation.
  • Modular sensing capabilities: We have multiple platform technologies that allow for easy re-engineering of an existing sensor towards new targets, including modular protein detection and modular nucleic acid detection. We also have numerous bespoke applications for small molecule sensing.
  • Clinically relevant sensitivity: Assays use existing biological machinery plus signal amplification as needed to detect clinically relevant analyte concentrations.
  • Assay format: Assays function in sample volumes as low as 8 uL and complex sample matrices including blood, suitable for minimally invasive fingerstick samples.
  • Readout options: Colorimetric or fluorescent readouts for varying levels of precision.
  • Storage and transport: Assays can be lyophilized for ease of storage and transport, eliminating the need for a cold chain.
  • Applications to date: Sensors for zinc, homocysteine, vitamins B12 and C, and multiple different protein targets.
Technology readiness level

This technology is at TRL 4, as it has been validated in a laboratory environment. Future work includes collaborating with sponsors to refine assay formats and develop new sensors, adapting the technology for practical deployment.


About Georgia Institute of Technology

Georgia Institute of Technology is a large, technology‑focused public research university in Atlanta with a strong applied research culture. Industry engages through the Georgia Tech Research Institute for contract R&D, a Midtown innovation district with co‑located corporate labs, and a statewide manufacturing extension to support scale‑up. A long‑standing partnership with a major academic medical center enables clinical translation, and a large co‑op program delivers a steady talent pipeline. Research is backed by competitive federal funding from NSF, NIH, DOE, DoD, and NASA. Technology commercialization is managed by the Georgia Tech Research Corporation, with dedicated licensing, corporate contracting, and startup support.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.